Annex C. OECD Health Division Survey on Health Care Provider Payment for Nuclear Medicine Diagnostic Services

The initial geographic scope of this study was defined as the 23 countries that are members of the European Union and the OECD as well as Australia, Canada, Japan and the United States. An invitation to nominate respondents to the OECD Health Division Survey on Health Care Provider Payment for Nuclear Medicine Diagnostic Services was sent in January 2018 all country delegates in the OECD Health Committee. Respondents were nominated in 26 countries, including 22 countries in the initial scope and Iceland, Israel, Norway and Switzerland. All nominated respondents were contacted between April and June 2018. By September 2018, responses were submitted by respondents from 16 countries, including 15 countries that were in the initial geographic scope of the study and Switzerland. Details are presented in the table below.

Table A C.1. Responses to OECD Health Division Survey
	Country	Respondent identified	Response received
In initial scope	Australia	Yes	Yes
	Austria	Yes	No
	Belgium	Yes	Yes
	Canada	Yes	Yes
	Czech Republic	Yes	Yes
	Denmark	Yes	Yes
	Estonia	Yes	No
	Finland	No	No
	France	Yes	Yes
	Germany	Yes	Yes
	Greece	No	No
	Hungary	No	No
	Ireland	Yes	No
	Italy	Yes	No
	Japan	Yes	Yes
	Latvia	Yes	Yes
	Lithuania	Yes	Yes
	Luxembourg	Yes	Yes
	Netherlands	Yes	Yes
	Poland	Yes	Yes
	Portugal	No	No
	Slovakia	No	No
	Slovenia	Yes	Yes
	Spain	Yes	No
	Sweden	Yes	Yes
	United Kingdom (England)	Yes	Yes
	United States	Yes	No
	N of "Yes" of countries in initial scope	22	16
	% of countries in initial scope	81%	59%
Not in initial scope	Chile	No	No
	Iceland	Yes	No
	Israel	Yes	No
	Korea	No	No
	Mexico	No	No
	New Zealand	No	No
	Norway	Yes	No
	Switzerland	Yes	Yes
	Turkey	No	No
	Total N of "Yes"	26	17
	% of all OECD countries	72%	47%
Source: OECD Health Division survey.

Annex C. OECD Health Division Survey on Health Care Provider Payment for Nuclear Medicine Diagnostic Services